Vectus Biosystems (ASX:VBS) Non Operating Income

: A$1.86 Mil (TTM As of Dec. 2022)

View and export this data going back to 2016. Start your Free Trial

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. Vectus Biosystems's non-recurring items for the six months ended in Dec. 2022 was A$0.56 Mil. Its non-recurring items for the trailing twelve months (TTM) ended in Dec. 2022 was A$1.86 Mil.

As of today (2023-06-09), Vectus Biosystems's share price is A$0.45. Vectus Biosystems's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2022 was A$-0.09. Therefore, Vectus Biosystems's PE Ratio without NRI ratio for today is At Loss.

Vectus Biosystems Non Operating Income Historical Data

The historical data trend for Vectus Biosystems's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Non Operating Income

0.05

0.08

1.30

Vectus Biosystems Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Non Operating Income										0.05	0.03	-	1.30	0.56

Vectus Biosystems Non Operating Income Calculation

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. Examples of NRI include gains (losses) from plant shutdown, lease-breaking fees, lawsuit, write-offs, write-downs, restructuring costs or sales of an investment, discontinued operations etc.

NRI can impact a company's reported income drastically.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1.86 Mil.

GuruFocus lists a PE Ratio without NRI, which is the price/earnings before NRI. We believe it more accurately reflects the valuation of the company.

Vectus Biosystems's PE Ratio without NRI Ratio for today is calculated as

PE Ratio without NRI	=	Share Price	/	EPS without NRI
	=	0.45	/	-0.09
	=	At Loss

Vectus Biosystems's Share Price of today is A$0.45.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vectus Biosystems's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2022 was A$-0.09.

Vectus Biosystems Non Operating Income Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectus Biosystems (ASX:VBS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Non Operating Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018

Website

http://www.vectusbiosystems.com.au

Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines